Use of Long Acting GnRH Antagonist to Prevent Ovarian HyperStimulation Syndrome (OHSS) in PCOS Women Undergoing COH for IVF
Phase of Trial: Phase III
Latest Information Update: 29 Apr 2016
At a glance
- Drugs Degarelix (Primary) ; Cetrorelix
- Indications Female infertility; Ovarian hyperstimulation syndrome; Polycystic ovary syndrome
- Focus Therapeutic Use
- 25 Apr 2016 Status changed from recruiting to completed.
- 02 Dec 2013 Planned end date changed from 1 May 2013 to 1 Dec 2014 as reported by ClinicalTrials.gov record.
- 13 Nov 2012 New trial record